• Entecavir and HBV Resistance: Meta-Analysis Findings

  2026-10-09

  Lumley and colleagues provide the first systematic review and meta-analysis to pool sequence-defined hepatitis B virus resistance estimates for entecavir and tenofovir over time. The analysis found low cumulative resistance to entecavir in treatment-naive populations, substantially higher resistance among nucleos(t)ide-experienced participants, and no pooled tenofovir resistance signal—although important evidence gaps limit interpretation.

• Sodium Chloride B7288: Product Overview

  2026-10-09

  Sodium chloride B7288 is a supplier-listed inorganic salt with the identity NaCl, molecular weight 58.44, CAS 7647-14-5, and stated purity of 98%. No matched paper evidence is available for this specific product.

• Uridine, Trisodium Salt: Evidence and Scope

  2026-10-08

  Explore Uridine, Trisodium Salt as a biochemical reagent for RNA metabolism and vascular research, while separating its established biochemical relevance from the RNA-only PRINT genome-engineering findings reported in Nature Biotechnology.

• Carbenoxolone Disodium: Product Overview

  2026-10-08

  Carbenoxolone disodium (SKU A8389) is listed by APExBIO as a research compound associated with 11β-hydroxysteroid dehydrogenase, gap junction communication, and related glucocorticoid signaling. No matched paper evidence was provided, so performance, selectivity, and disease-model relevance cannot be independently assessed.

• High-Yield Rabbit Pharming: What the Study Shows

  2026-10-07

  Song et al. developed a targeted rabbit knock-in line that uses the CSN2 regulatory region to drive milk-associated expression of the tdTomato reporter. Homozygous animals reportedly reached 15–20 g/L in milk, supporting targeted promoter selection as a promising strategy, although the study remains an early platform demonstration rather than proof of therapeutic-product performance.

• Toremifene Citrate: Evidence from the Reference Paper

  2026-10-07

  The reference paper presents Toremifene Citrate as a nonsteroidal antiestrogen and oral selective estrogen receptor modulator for hormone receptor-positive or unknown-status advanced breast cancer in postmenopausal women. Its principal contribution is a clinically oriented synthesis connecting estrogen receptor pharmacology with comparative efficacy, safety monitoring, drug interactions, and oncology nursing considerations.

• D-Mannitol B2090: Product Overview

  2026-10-06

  D-Mannitol B2090 is a supplier-described biochemical reagent for conceptual osmotic regulation research, renal function studies, and diuretic mechanism investigation. No matched paper evidence was provided for this specific product.

• Leucovorin Calcium in Gastric Cancer Models

  2026-10-06

  Leucovorin Calcium, or calcium folinate, is relevant to research on reduced folate biology and methotrexate response. A 2025 gastric cancer assembloid study shows why stromal context can change drug sensitivity, but it does not directly establish leucovorin-specific effects or clinical utility.

• Uridine, Trisodium Salt: What the Evidence Shows

  2026-10-05

  Uridine, Trisodium Salt is examined here as a nucleoside analog within RNA metabolism, vascular biology, and RNA-mediated genome engineering. Rather than treating a commercial reagent as proof of platform performance, this evidence-led analysis separates supplier specifications from what PRINT research actually demonstrated.

• Sodium Phosphate Dibasic: Evidence and Limits

  2026-10-05

  Sodium phosphate dibasic, or Na2HPO4, is a water-soluble phosphate salt used for pH control in biochemical and molecular biology contexts. Its buffering role can support assay consistency, but it is not direct evidence for the toxicity, efficacy, or ecological behavior of sulfamonomethoxine.

• Gastric Cancer Assembloids and Stromal Drug Response

  2026-10-04

  Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine matched tumor organoids with stromal subpopulations from the same tumor tissue. Their findings show that stromal composition can alter gene expression and drug sensitivity, supporting more physiologically relevant studies of tumor–microenvironment interactions and treatment resistance.

• Sodium Citrate in 3D SERS Evidence

  2026-10-03

  Explore how sodium citrate may intersect with reproducible 3D SERS nanostructures without confusing chemical plausibility with demonstrated causation. This evidence-focused analysis examines the reference study, product specifications, research gaps, and responsible interpretation.

• Carbenoxolone disodium: Lab Workflow Guide

  2026-10-02

  Carbenoxolone disodium (SKU A8389) is an exploratory 11β-hydroxysteroid dehydrogenase inhibitor for studying glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best applied in controlled enzyme, cell, or tissue workflows with matched vehicle and orthogonal controls, not as a selective in vivo efficacy probe or clinical treatment.

• InstaBlue Protein Stain Solution: Practical Gel Guide

  2026-10-01

  InstaBlue Protein Stain Solution provides rapid, fixation-free visualization of protein bands in polyacrylamide gels using a ready-to-use Coomassie Brilliant Blue formulation. It is suited to routine protein electrophoresis analysis and workflows that may lead to mass spectrometry, but staining performance, quantitative linearity, and downstream recovery should be validated for each gel system and sample type.

• Polymer Pen Lithography for 3D SERS Arrays

  2026-10-01

  The reference study introduces polymer pen lithography to pattern three-dimensional polyethylenimine structures that template ordered gold nanoparticle nanoclusters for surface-enhanced Raman scattering. Its combination of structural programmability, high enhancement, and low spot-to-spot variation offers a practical route toward reproducible SERS substrates without relying exclusively on complex high-resolution lithography.

7944 records 1/530 page Next 12345 下5页 Last page